Jump to content

P2Y12 inhibitors: Difference between revisions

no edit summary
(Created page with "'''P2Y<sub>12</sub> inhibitors''' are antiplatelet drugs. They are are often used in combination with acetylsalicylic acid, which is called ''dual antiplatelet therapy'' (<abbr>DAPT</abbr>). However, they may also be used alone. == Compounds == * Clopidogrel (Plavix®) * Prasugrel (Efient®) * Ticagrelor (Brilique®) == Mechanism of action == These drugs inhibit the P2Y12 receptor, an ADP receptor which is found on platelets. This receptor binds ADP which is r...")
 
No edit summary
 
Line 1: Line 1:
'''P2Y<sub>12</sub> inhibitors''' are [[antiplatelet drugs]]. They are are often used in combination with [[acetylsalicylic acid]], which is called ''dual antiplatelet therapy'' (<abbr>DAPT</abbr>). However, they may also be used alone.
<section begin="clinical biochemistry" />'''P2Y<sub>12</sub> inhibitors''' are [[antiplatelet drugs]]. They are are often used in combination with [[acetylsalicylic acid]], which is called ''dual antiplatelet therapy'' (<abbr>DAPT</abbr>). However, they may also be used alone.<section end="clinical biochemistry" />


== Compounds ==
== Compounds ==
* Clopidogrel (Plavix®)
* Clopidogrel (Plavix®)
* Prasugrel (Efient®)
* Prasugrel (Efient®)
Line 12: Line 11:
== Pharmacokinetics ==
== Pharmacokinetics ==
Clopidogrel and prasugrel are irreversible inhibitors, while ticagrelor is a reversible inhibitor. They have similar half-lives but the effect lasts longer for the irreversible inhibitors, as new platelets must be formed for the effect to pass.
Clopidogrel and prasugrel are irreversible inhibitors, while ticagrelor is a reversible inhibitor. They have similar half-lives but the effect lasts longer for the irreversible inhibitors, as new platelets must be formed for the effect to pass.
<noinclude>[[Category:Pharmacology]]
 
== Monitoring ==
<section begin="clinical biochemistry" />One can monitor P2Y<sub>12</sub> therapeutic effect with [[platelet aggregometry]] with ADP, but this is not routinely performed. There are no known uses for this, as a therapeutic reference range has not been established.<section end="clinical biochemistry" /><noinclude>
[[Category:Pharmacology]]
</noinclude>
</noinclude>